Gilbert Ray Cisneros, Jr. (D-CA) Stock Trades & Portfolio (2026 Tracker)
Quick Facts & Congressional Trading Direct Answers
What was Gilbert Ray Cisneros, Jr.'s latest stock trade?
According to official STOCK Act filings, Gilbert Ray Cisneros, Jr.'s most recently recorded transaction was a purchase of BHE (Benchmark Electronics, Inc. Common Stock (BHE)) on 2026-10-01 (disclosed on 2026-10-12), valued between $15K and $50K.
What is Gilbert Ray Cisneros, Jr.'s primary traded stock sector?
Congressional disclosures reflect strategic exposure across large-cap technology, defense, and healthcare equities subject to committee jurisdictions.
When must members of Congress disclose stock trades?
Under the Stop Trading on Congressional Knowledge Act of 2012 (STOCK Act), lawmakers, spouses, and dependent children are legally required to file Periodic Transaction Reports (PTR) within 30 days of trade notification and no later than 45 days after execution.
Recent Disclosed Congressional Stock Transactions
Periodic Transaction Reports (PTR) disclosed under the Stop Trading on Congressional Knowledge Act of 2012 (STOCK Act):
| Transaction Date | Filing Date | Ticker | Action | Disclosed Range | Account Owner | Asset Description | Official Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-01 | 2026-10-12 | BHE | BUY | $15K – $50K | Self | Benchmark Electronics, Inc. Common Stock (BHE) | Filing PTR |
| 2026-10-01 | 2026-10-12 | THR | EXCHANGE | $15K – $50K | Self | Thermon Group Holdings, Inc. Common Stock (THR) | Filing PTR |
| 2026-09-29 | 2026-10-12 | AEIS | BUY | $1K – $15K | Self | Advanced Energy Industries, Inc. - Common Stock (AEIS) | Filing PTR |
| 2026-09-29 | 2026-10-12 | ALKS | BUY | $1K – $15K | Self | Alkermes plc - Ordinary Shares (ALKS) | Filing PTR |
| 2026-09-29 | 2026-10-12 | ALGM | BUY | $1K – $15K | Self | Allegro MicroSystems, Inc. - Common Stock (ALGM) | Filing PTR |
| 2026-09-29 | 2026-10-12 | ATRC | SELL | $1K – $15K | Self | AtriCure, Inc. - Common Stock (ATRC) | Filing PTR |
| 2026-09-29 | 2026-10-12 | BBIO | SELL | $1K – $15K | Self | BridgeBio Pharma, Inc. - Common Stock (BBIO) | Filing PTR |
| 2026-09-29 | 2026-10-12 | CYTK | BUY | $1K – $15K | Self | Cytokinetics, Incorporated - Common Stock (CYTK) | Filing PTR |
| 2026-09-29 | 2026-10-12 | GTES | BUY | $1K – $15K | Self | Gates Industrial Corporation Ltd. Common Shares (GTES) | Filing PTR |
| 2026-09-29 | 2026-10-12 | HALO | SELL | $1K – $15K | Self | Halozyme Therapeutics, Inc. - Common Stock (HALO) | Filing PTR |
| 2026-09-29 | 2026-10-12 | — | SELL | $100K – $250K | Self | Imperial, CA, Irrigation District Bonds | Filing PTR |
| 2026-09-29 | 2026-10-12 | — | BUY | $250K – $500K | Self | Indiana Finance Authority Health System Rev Bonds | Filing PTR |
| 2026-09-29 | 2026-10-12 | ITT | SELL | $15K – $50K | Self | ITT Inc. Common Stock (ITT) | Filing PTR |
| 2026-09-29 | 2026-10-12 | MTSI | SELL | $15K – $50K | Self | MACOM Technology Solutions Holdings, Inc. - Common Stock (MTSI) | Filing PTR |
| 2026-09-29 | 2026-10-12 | OXM | SELL | $1K – $15K | Self | Oxford Industries, Inc. Common Stock (OXM) | Filing PTR |
| 2026-09-29 | 2026-10-12 | PRAX | BUY | $1K – $15K | Self | Praxis Precision Medicines, Inc. - Common Stock (PRAX) | Filing PTR |
| 2026-09-29 | 2026-10-12 | SMTC | SELL | $1K – $15K | Self | Semtech Corporation - Common Stock (SMTC) | Filing PTR |
| 2026-09-29 | 2026-10-12 | TNDM | BUY | $1K – $15K | Self | Tandem Diabetes Care, Inc. - Common Stock (TNDM) | Filing PTR |
| 2026-09-29 | 2026-10-12 | RARE | BUY | $1K – $15K | Self | Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) | Filing PTR |
| 2026-09-29 | 2026-10-12 | YETI | BUY | $1K – $15K | Self | YETI Holdings, Inc. Common Stock (YETI) | Filing PTR |
Gilbert Ray Cisneros, Jr. Stock Trades & Congressional Portfolio (2026)
Gilbert Ray Cisneros, Jr. is a member of the U.S. House of Representatives representing D-CA (CA). According to periodic transaction reports (PTR) filed under the Stop Trading on Congressional Knowledge Act of 2012 (STOCK Act), Gilbert Ray Cisneros, Jr. and immediate family members (including spouse transactions) have disclosed 200 stock and financial asset transactions across 475 tickers over recent reporting cycles, representing an aggregate disclosed trading volume exceeding $24.7M.
Under the STOCK Act, members of Congress are mandated to report securities transactions over $1,000 within 30 to 45 days of execution. Tracking legislative stock disclosures provides critical visibility into institutional positioning, sector exposure, and potential intersections between congressional committee jurisdictions and private capital flows.
Primary Regulatory Source: Official Periodic Transaction Reports (PTR) and annual financial disclosures for Gilbert Ray Cisneros, Jr. are mandated under the Stop Trading on Congressional Knowledge Act of 2012 (STOCK Act) and publicly archived by the Office of the Clerk of the U.S. House of Representatives. Gemral Edge cross-verifies all disclosed tickers and amounts directly against these official government filings.
Verified from official public disclosure — record 20035622
Congressional Committee Assignments & Oversight Jurisdiction
Official committee and subcommittee assignments in the U.S. Congress, indicating policy jurisdiction and regulatory oversight:
| Committee / Subcommittee | Role | Classification |
|---|---|---|
| House Committee on Armed Services | Member | Standing Committee |
| House Committee on Small Business | Member | Standing Committee |
| House Committee on Armed Services — Intelligence and Special Operations | Member | Subcommittee |
| House Committee on Armed Services — Military Personnel | Member | Subcommittee |
| House Committee on Small Business — Contracting and Infrastructure | Ranking Member | Subcommittee |
| House Committee on Small Business — Oversight, Investigations, and Regulations | Member | Subcommittee |
Related Breaking Regulatory Disclosures
Real-time regulatory disclosures and transaction alerts for Gilbert Ray Cisneros, Jr. are tracked continuously via Gemral Edge Stories and Breaking Intelligence News.
Congressional Trading Context & STOCK Act Compliance
Congressional trading disclosures under the STOCK Act encompass transactions executed by the member, their spouse, and dependent children. In many prominent portfolios, such as that of Gilbert Ray Cisneros, Jr., a significant share of capital activity is executed by spouses (for instance, venture investments, call options, and tech equity transactions by Paul Pelosi). Because federal law allows up to 45 days between trade execution and public disclosure, market observers often analyze these filings retrospectively to evaluate long-term thematic positioning rather than short-term market timing.
Public records indicate an estimated one-year time-weighted return of N/A. Gemral Edge normalizes disclosure amounts using geometric midpoints of mandated reporting ranges ($1,001–$15,000, $15,001–$50,000, $50,001–$100,000, $100,001–$250,000, $250,001–$500,000, $500,001–$1,000,000, $1,000,001–$5,000,000, and over $5,000,000) to estimate total volume and performance without speculative assumptions.
Alternative Financial & Congressional Trading Platforms
Compare Gemral Edge's quantitative analytics and real-time STOCK Act tracking against other platforms:
- Gemral Edge vs Quiver Quantitative: Feature, Latency & Coverage Comparison
- Gemral Edge vs Capitol Trades: SPEED & Federal Contract Cross-Referencing
- Gemral Edge vs Unusual Whales: Government Contracts & Dark Pool Flow vs STOCK Act
- Gemral Edge vs OpenInsider: Corporate SEC Form 4 vs Congressional Trading Radars
- Gemral Edge vs Dataroma: Superinvestor 13F Cloning vs Multi-Pillar Convergence
- Gemral Edge vs Barchart: Broad Market-Data Screeners vs Federal Contract Intelligence
- Gemral Edge vs TipRanks: Analyst-Ratings Smart Score vs Congressional & Contract Convergence
Frequently asked questions
What stocks does Gilbert Ray Cisneros, Jr. trade most frequently?
Congressional disclosures show concentrated exposure in major equities, including large-cap technology, defense, and healthcare equities. Both direct equity shares and leveraged options (including long-dated LEAP call options) have been filed under the STOCK Act.
Are members of Congress allowed to trade individual stocks?
Yes. Under the Stop Trading on Congressional Knowledge Act of 2012 (STOCK Act), lawmakers, spouses, and dependent children are legally permitted to trade publicly traded securities, provided all transactions exceeding $1,000 are publicly filed within 30 to 45 days of execution.
How is trading volume and performance estimated for Gilbert Ray Cisneros, Jr.?
Gemral Edge normalizes mandated statutory transaction ranges ($1,001–$15,000 up to over $5,000,000) using geometric midpoints, aggregating disclosed transactions from official congressional clerks for research and civic transparency, representing an aggregate disclosed volume exceeding $24.7M.
Does Gilbert Ray Cisneros, Jr. trade stocks personally or through a spouse?
Congressional disclosures encompass transactions executed by the member, their spouse, and dependent children. All filings report the disclosed ownership entity pursuant to House and Senate ethics guidelines.
Data intelligence from public filings — not investment advice.
Explore Gemral Edge
- Zoe Lofgren — trades
- Nancy Pelosi — trades
- George Whitesides — trades
- US Election Betting Odds & Stock Impact Tracker
- U.S. Regional Bank CRE Debt Wall, Liquidity Stress, BTFP…
- U.S. Strategic Bitcoin Reserve Act Odds & Gold Precedent
- Gemral Edge vs Quiver Quantitative
- Gemral Edge vs Capitol Trades
- Gemral Edge vs Unusual Whales
- Gemral Edge vs OpenInsider
- Capitol Trades leaderboard
- Federal contract explorer
- Lobbying velocity index
- Live signal radar
- Macro & liquidity radar
- 2026 Senate battleground
Risk Disclaimer
Trading and investing in digital assets, financial instruments, and predictive events involve substantial risk of loss and are not suitable for every investor. The predictive intelligence, probability distributions, historical precedents, and scenario modeling presented on this page are compiled for informational and research purposes only and do not constitute financial, investment, legal, or tax advice. Past performance and statistical precedents do not guarantee future outcomes. Always conduct independent due diligence before committing capital.